216 related articles for article (PubMed ID: 29188513)
1. Optogenetic Retinal Gene Therapy with the Light Gated GPCR Vertebrate Rhodopsin.
Gaub BM; Berry MH; Visel M; Holt A; Isacoff EY; Flannery JG
Methods Mol Biol; 2018; 1715():177-189. PubMed ID: 29188513
[TBL] [Abstract][Full Text] [Related]
2. Optogenetic Vision Restoration Using Rhodopsin for Enhanced Sensitivity.
Gaub BM; Berry MH; Holt AE; Isacoff EY; Flannery JG
Mol Ther; 2015 Oct; 23(10):1562-71. PubMed ID: 26137852
[TBL] [Abstract][Full Text] [Related]
3. Restoration of high-sensitivity and adapting vision with a cone opsin.
Berry MH; Holt A; Salari A; Veit J; Visel M; Levitz J; Aghi K; Gaub BM; Sivyer B; Flannery JG; Isacoff EY
Nat Commun; 2019 Mar; 10(1):1221. PubMed ID: 30874546
[TBL] [Abstract][Full Text] [Related]
4. Improved CoChR Variants Restore Visual Acuity and Contrast Sensitivity in a Mouse Model of Blindness under Ambient Light Conditions.
Ganjawala TH; Lu Q; Fenner MD; Abrams GW; Pan ZH
Mol Ther; 2019 Jun; 27(6):1195-1205. PubMed ID: 31010741
[TBL] [Abstract][Full Text] [Related]
5. Prospects of Optogenetic Prosthesis of the Degenerative Retina of the Eye.
Ostrovsky MA; Kirpichnikov MP
Biochemistry (Mosc); 2019 May; 84(5):479-490. PubMed ID: 31234763
[TBL] [Abstract][Full Text] [Related]
6. Mouse models of human retinal disease caused by expression of mutant rhodopsin. A valuable tool for the assessment of novel gene therapies.
Nour M; Naash MI
Adv Exp Med Biol; 2003; 533():173-9. PubMed ID: 15180262
[No Abstract] [Full Text] [Related]
7. [Retinitis pigmentosa: eye sight restoration by optogenetic therapy].
Roska B; Busskamp V; Sahel JA; Picaud S
Biol Aujourdhui; 2013; 207(2):109-21. PubMed ID: 24103341
[TBL] [Abstract][Full Text] [Related]
8. Functional Availability of ON-Bipolar Cells in the Degenerated Retina: Timing and Longevity of an Optogenetic Gene Therapy.
Kralik J; Kleinlogel S
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768944
[TBL] [Abstract][Full Text] [Related]
9. Assessment of visual function and retinal structure following acute light exposure in the light sensitive T4R rhodopsin mutant dog.
Iwabe S; Ying GS; Aguirre GD; Beltran WA
Exp Eye Res; 2016 May; 146():341-353. PubMed ID: 27085210
[TBL] [Abstract][Full Text] [Related]
10. Salvaging ruins: reverting blind retinas into functional visual sensors.
Mutter M; Swietek N; Münch TA
Methods Mol Biol; 2014; 1148():149-60. PubMed ID: 24718800
[TBL] [Abstract][Full Text] [Related]
11. Strategies for expanding the operational range of channelrhodopsin in optogenetic vision.
Mutter M; Münch TA
PLoS One; 2013; 8(11):e81278. PubMed ID: 24312285
[TBL] [Abstract][Full Text] [Related]
12. Optogenetic Therapy for Visual Restoration.
Sakai D; Tomita H; Maeda A
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499371
[TBL] [Abstract][Full Text] [Related]
13. Opsins for vision restoration.
Simon CJ; Sahel JA; Duebel J; Herlitze S; Dalkara D
Biochem Biophys Res Commun; 2020 Jun; 527(2):325-330. PubMed ID: 31982136
[TBL] [Abstract][Full Text] [Related]
14. Increased sensitivity to light-induced damage in a mouse model of autosomal dominant retinal disease.
White DA; Fritz JJ; Hauswirth WW; Kaushal S; Lewin AS
Invest Ophthalmol Vis Sci; 2007 May; 48(5):1942-51. PubMed ID: 17460245
[TBL] [Abstract][Full Text] [Related]
15. Degenerated Cones in Cultured Human Retinas Can Successfully Be Optogenetically Reactivated.
Kamar S; Howlett MHC; Klooster J; Graaff W; Csikós T; Rabelink MJWE; Hoeben RC; Kamermans M
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947650
[TBL] [Abstract][Full Text] [Related]
16. Movin' on Down the Line.
Wang FM
J Pediatr Ophthalmol Strabismus; 2017 Jan; 54(1):12-13. PubMed ID: 28128843
[No Abstract] [Full Text] [Related]
17. Effect of Rhodopsin Phosphorylation on Dark Adaptation in Mouse Rods.
Berry J; Frederiksen R; Yao Y; Nymark S; Chen J; Cornwall C
J Neurosci; 2016 Jun; 36(26):6973-87. PubMed ID: 27358455
[TBL] [Abstract][Full Text] [Related]
18. Transgene is specifically and functionally expressed in retinal inhibitory interneurons in the VGAT-ChR2-EYFP mouse.
Xu GZ; Cui LJ; Liu AL; Zhou W; Gong X; Zhong YM; Yang XL; Weng SJ
Neuroscience; 2017 Nov; 363():107-119. PubMed ID: 28918256
[TBL] [Abstract][Full Text] [Related]
19. Advances in Ophthalmic Optogenetics: Approaches and Applications.
Prosseda PP; Tran M; Kowal T; Wang B; Sun Y
Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204770
[TBL] [Abstract][Full Text] [Related]
20. Optogenetic approaches to therapy for inherited retinal degenerations.
De Silva SR; Moore AT
J Physiol; 2022 Nov; 600(21):4623-4632. PubMed ID: 35908243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
